Application of stereotactic body radiotherapy in small hepatocellular carcinoma

Wenjun LIU; Dan DU; Baojie CHEN; Ting YAO; Xianfu LI

doi:10.3969/j.issn.1001-5256.2021.05.050

Volume 37 Issue 5

May 2021

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(5): 1212-1215

PDF( 1879 KB)

Application of stereotactic body radiotherapy in small hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.05.050

Department of Radiotherapy, Affiliated Hospital of Chuanbei Medical College, Nanchong, Sichuan 637000, China

Received Date: 2020-10-08
Accepted Date: 2020-11-09
Published Date: 2021-05-20

Abstract

Abstract

At present, hepatic resection (HR) and radiofrequency ablation of (RFA) are the main radical treatment methods for small hepatocellular carcinoma (sHCC), while stereotactic body radiotherapy (SBRT) is developing rapidly and there is an increasing number of reports on the effective treatment of sHCC with SBRT. This article introduces the technical advantages, therapeutic dose, and fractionation scheme of SBRT in the treatment of sHCC, as well as the limit of normal liver tissue and the protection of surrounding organs at risk. This article also compares the efficacy of SBRT versus HR and RFA in the treatment of sHCC and briefly describes the adverse reactions of SBRT in the treatment of sHCC. Previous studies have shown that for some sHCC cases, SBRT has an equal or even better clinical effect than HR and RFA, with controllable toxicity. Therefore, SBRT is expected to become another radical treatment method for sHCC.
- Liver Neoplasms,
- Radiosurgery,
- Radiotherapy Dosage,
- Treatment Outcome

FullText(HTML)

References(35)

References

[1]	GE WL. Prognostic analysis of regular or irregular hepatectomy for single small hepatocellular carcinoma[J]. J Hepatobiliary Surg, 2017, 25 (3): 181-185. DOI: 10.3969/j.issn.1006-4761.2017.03.007. 葛万灵. 规则性或非规则性肝癌切除术治疗单发小肝癌的预后分析[J]. 肝胆外科杂志, 2017, 25(3): 181-185. DOI: 10.3969/j.issn.1006-4761.2017.03.007.
[2]	HE J, MAO YS, SHEN K, et al. Clinical Oncology[M]. Beijing: People's Health publishing house, 2016: 450. (in Chinese) 赫捷, 毛友生, 沈铿, 等. 临床肿瘤学[M]. 北京: 人民卫生出版社, 2016: 450.
[3]	Medical Administration of the National Health Commission of the people's Republic of China. Standard for diagnosis and treatment of primary liver cancer (2019 Edition)[J]. J Clin Hepatol, 2020, 36 (2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007. 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
[4]	JEONG Y, JUNG J, CHO B, et al. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma[J]. BMC Cancer, 2018, 18(1): 416. DOI: 10.1186/s12885-018-4340-7.
[5]	ZENG ZC, SUN JG, LANG JY. Radiotherapy for hepatocellular carcinoma downstaging: From palliative care to radical treatment[J]. J Clin Hepatol, 2020, 36(2): 258-262. DOI: 10.3969/j.issn.1001-5256.2020.02.003. 曾昭冲, 孙建国, 郎锦义. 肝细胞癌放疗降期——从姑息走向根治[J]. 临床肝胆病杂志, 2020, 36(2): 258-262. DOI: 10.3969/j.issn.1001-5256.2020.02.003.
[6]	ZENG ZC. Stereotactic radiotherapy for liver cancer is a radical method worth exploring[J]. Liver, 2020, 25(7): 665-667. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN202007005.htm 曾昭冲. 肝癌立体定向放疗是值得探索的根治性方法[J]. 肝脏, 2020, 25(7): 665- 667. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN202007005.htm
[7]	ZENG ZC, SEONG J, YOON SM, et al. Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting[J]. Liver Cancer, 2017, 6(4): 264-274. DOI: 10.1159/000475768.
[8]	WANG PM, HSU WC, CHUNG NN, et al. Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients[J]. Radiat Oncol, 2014, 9: 18. DOI: 10.1186/1748-717X-9-18.
[9]	ZHANG T, SUN J, HE WP, et al. Clinical effect of CyberKnife stereotactic radiosurgery in treatment of patients with small hepatocellular carcinoma[J]. J Clin Hepatol, 2017, 33(4): 694-698. DOI: 10.3969/j.issn.1001-5256.2017.04.019. 张弢, 孙静, 何卫平, 等. 射波刀立体定向放射治疗小肝癌的临床效果[J]. 临床肝胆病杂志, 2017, 33(4): 694-698. DOI: 10.3969/j.issn.1001-5256.2017.04.019.
[10]	JIN H, CHALKIDOU A, HAWKINS M, et al. Cost-effectiveness analysis of stereotactic ablative body radiation therapy compared with surgery and radiofrequency ablation in two patient cohorts: Metastatic liver cancer and hepatocellular carcinoma[J]. Clin Oncol (R Coll Radiol), 2021, 33(3): e143-e154. DOI: 10.1016/j.clon.2020.08.010.
[11]	LU L, DIACONU C, DJEMIL T, et al. Intra- and inter-fractional liver and lung tumor motions treated with SBRT under active breathing control[J]. J Appl Clin Med Phys, 2018, 19(1): 39-45. DOI: 10.1002/acm2.12220.
[12]	HU Y, ZHOU YK, CHEN YX, et al. 4D-CT scans reveal reduced magnitude of respiratory liver motion achieved by different abdominal compression plate positions in patients with intrahepatic tumors undergoing helical tomotherapy[J]. Med Phys, 2016, 43(7): 4335. DOI: 10.1118/1.4953190.
[13]	CHEN YX, ZHUANG Y, YANG P, et al. Helical IMRT-based stereotactic body radiation therapy using an abdominal compression technique and modified fractionation regimen for small hepatocellular carcinoma[J]. Technol Cancer Res Treat, 2020, 19: 1533033820937002. DOI: 10.1177/1533033820937002.
[14]	YOON SM, KIM SY, LIM YS, et al. Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase Ⅱ clinical trial[J]. Clin Mol Hepatol, 2020, 26(4): 506-515. DOI: 10.3350/cmh.2020.0038.
[15]	GKIKA E, TANADINI-LANG S, KIRSTE S, et al. Interobserver variability in target volume delineation of hepatocellular carcinoma: An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO)[J]. Strahlenther Onkol, 2017, 193(10): 823-830. DOI: 10.1007/s00066-017-1177-y.
[16]	SHETH N, OSBORN V, LEE A, et al. Stereotactic ablative radiotherapy fractionation for hepatocellular carcinoma in the United States[J]. Cureus, 2020, 12(6): e8675. DOI: 10.7759/cureus.8675.
[17]	PARK HC, SEONG J, HAN KH, et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys, 2002, 54(1): 150-155. DOI: 10.1016/s0360-3016(02)02864-x.
[18]	SUN J, ZHANG T, WANG J, et al. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)[J]. BMC Cancer, 2019, 19(1): 846. DOI: 10.1186/s12885-019-6063-9.
[19]	PARK S, JUNG J, CHO B, et al. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2020, 35(11): 1953-1959. DOI: 10.1111/jgh.15011.
[20]	OHRI N, TOMÉ WA, MÉNDEZ ROMERO A, et al. Local control after stereotactic body radiation therapy for liver tumors[J]. Int J Radiat Oncol Biol Phys, 2018. DOI: 10.1016/j.ijrobp.2017.12.288.
[21]	GUHA C, KAVANAGH BD. Hepatic radiation toxicity: Avoidance and amelioration[J]. Semin Radiat Oncol, 2011, 21(4): 256-263. DOI: 10.1016/j.semradonc.2011.05.003.
[22]	JUNG J, YOON SM, KIM SY, et al. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: Clinical and dose-volumetric parameters[J]. Radiat Oncol, 2013, 8: 249. DOI: 10.1186/1748-717X-8-249.
[23]	SON SH, CHOI BO, RYU MR, et al. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication[J]. Int J Radiat Oncol Biol Phys, 2010, 78(4): 1073-1080. DOI: 10.1016/j.ijrobp.2009.09.009.
[24]	SU TS, LIANG P, LU HZ, et al. Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients[J]. J Surg Oncol, 2016, 113(2): 181-187. DOI: 10.1002/jso.24128.
[25]	MOORE A, COHEN-NAFTALY M, TOBAR A, et al. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable hepatocellular carcinoma[J]. Radiat Oncol, 2017, 12(1): 163. DOI: 10.1186/s13014-017-0899-4.
[26]	KUBO K, KIMURA T, AIKATA H, et al. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma[J]. Hepatol Res, 2018, 48(9): 701-707. DOI: 10.1111/hepr.13063.
[27]	SU TS, LIANG P, LIANG J, et al. Long-term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys, 2017, 98(3): 639-646. DOI: 10.1016/j.ijrobp.2017.02.095.
[28]	SUN J, WANG Q, HONG ZX, et al. Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤5 cm): A propensity score analysis[J]. Hepatol Int, 2020, 14(5): 788-797. DOI: 10.1007/s12072-020-10088-0.
[29]	SEO YS, KIM MS, YOO HJ, et al. Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: A Markov model-based analysis[J]. Cancer Med, 2016, 5(11): 3094-3101. DOI: 10.1002/cam4.893.
[30]	WAHL DR, STENMARK MH, TAO Y, et al. Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma[J]. J Clin Oncol, 2016, 34(5): 452-459. DOI: 10.1200/JCO.2015.61.4925.
[31]	KIM N, CHENG J, JUNG I, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma[J]. J Hepatol, 2020, 73(1): 121-129. DOI: 10.1016/j.jhep.2020.03.005.
[32]	PAN CC, KAVANAGH BD, DAWSON LA, et al. Radiation-associated liver injury[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): s94-s100. DOI: 10.1016/j.ijrobp.2009.06.092.
[33]	BAUMANN BC, WEI J, PLASTARAS JP, et al. Stereotactic Body Radiation Therapy (SBRT) for hepatocellular carcinoma: High rates of local control with low toxicity[J]. Am J Clin Oncol, 2018, 41(11): 1118-1124. DOI: 10.1097/COC.0000000000000435.
[34]	KIM JW, SEONG J, LEE IJ, et al. Phase Ⅰ dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma[J]. Oncotarget, 2016, 7(26): 40756-40766. DOI: 10.18632/oncotarget.9450.
[35]	DOBRZYCKA M, SPYCHALSKI P, ROSTKOWSKA O, et al. Stereotactic body radiation therapy for early-stage hepatocellular carcinoma - a systematic review on outcome[J]. Acta Oncol, 2019, 58(12): 1706-1713. DOI: 10.1080/0284186X.2019.1657942.

Relative Articles

[1]	Xiaofang ZHAO, Aimin ZHANG, Wengang LI, Jing SUN, Xiaoyun CHANG, Tao ZHANG, Weiping HE, Xuezhang DUAN. Efficacy and safety of stereotactic body radiation therapy in treatment of patients with unresectable cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2657-2662. doi: 10.3969/j.issn.1001-5256.2023.11.021
[2]	Xiaoquan JI, Aimin ZHANG, Tao ZHANG, Wengang LI, Weiping HE, Jing SUN, Xuezhang DUAN. Efficacy and safety of sequential lenvatinib therapy after stereotactic body radiotherapy in treatment of advanced primary liver cancer[J]. Journal of Clinical Hepatology, 2021, 37(9): 2120-2124. doi: 10.3969/j.issn.1001-5256.2021.09.023
[3]	WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018
[4]	Zhang AiMin, Chang XiaoYun, Li WenGang, Han Ping, Xue Hui, Wang Hui, Duan XueZhang. Clinical effect of Cyber Knife radiosurgery in locally advanced pancreatic cancer or pancreatic cancer with distant metastasis[J]. Journal of Clinical Hepatology, 2019, 35(1): 143-146. doi: 10.3969/j.issn.1001-5256.2019.01.027
[5]	Wang ChunMei, Ceng JianTing, Luo XianZhang, Liu Ya. Clinical effect of S-1 in treatment of circulating tumor cell-positive patients after radical surgery for primary hepatic carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(3): 513-516. doi: 10.3969/j.issn.1001-5256.2018.03.012
[6]	Ye HaiWen, Deng Yong, Zhang LingQiang, Wang HaiJiu, Zhou Ying, Xu XiaoLei, Fan HaiNing. Influence of HBV DNA load on surgical outcome of hepatitis B-associated liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(9): 1995-1998. doi: 10.3969/j.issn.1001-5256.2018.09.035
[7]	An DongJun, An Lin, Zhang Cheng, Zhao WeiAn, Han Li. Efficacy of laparoscopic microwave ablation in treatment of malignant liver tumors[J]. Journal of Clinical Hepatology, 2017, 33(11): 2158-2161. doi: 10.3969/j.issn.1001-5256.2017.11.021
[8]	Li Huan, Sun Jing, Zhang Tao, Fan YuZe, Sun YingZhe, He WeiPing, Duan XueZhang. Effect of Cyber Knife radiosurgery on survival rate of patients with recurrent liver cancer after surgery[J]. Journal of Clinical Hepatology, 2017, 33(12): 2337-2341. doi: 10.3969/j.issn.1001-5256.2017.12.016
[9]	Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014
[10]	Zhang Tao, Sun Jing, He WeiPing, Li Huan, Wang Hui, Sun YingZhe, Po JunJie, Zhang JunHua, Xu HuiJun, Duan XueZhang. Clinical effect of Cyber Knife stereotactic radiosurgery in treatment of patients with small hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(4): 694-698. doi: 10.3969/j.issn.1001-5256.2017.04.019
[11]	Ci DanWangJiu, Chang ZhiHui, Zhao XiangXuan, Lin Kun, Zhang Qiang, Lu ZaiMing, Wang XiaoMing. Effect of continuous irradiation with ~(125)I radioactive seeds in inhibiting HepG2 cell proliferation and related mechanisms[J]. Journal of Clinical Hepatology, 2016, 32(10): 1920-1924. doi: 10.3969/j.issn.1001-5256.2016.10.019
[12]	Ji HongBing, Chen ZhongHua. Therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancre-atic cancer[J]. Journal of Clinical Hepatology, 2016, 32(3): 537-540. doi: 10.3969/j.issn.1001-5256.2016.03.030
[13]	Sun Jing, Po JunJie, Fan YuZe, He WeiPing, Li Huan, Sun YingZhe, Wang Hui, Duan XueZhang. Effect of stereotactic body radiotherapy versus intensity-modulated radiotherapy in primary liver cancer patients with secondary malignant tumor of vertebra[J]. Journal of Clinical Hepatology, 2016, 32(6): 1135-1138. doi: 10.3969/j.issn.1001-5256.2016.06.023
[14]	Hu CaiXia, Zheng JiaSheng, Cui ShiChang, Qian ZhiLing. Efficacy of nutritional intervention in patients with primary hepatocellular carcinoma treated by transcatheter arterial chemoembolization[J]. Journal of Clinical Hepatology, 2015, 31(4): 569-572. doi: 10.3969/j.issn.1001-5256.2015.04.022
[15]	Zhou YuanYuan, Zhang SiXing, Zheng QingPing, Shi ChengLiang, Luo ZhanXiong, Li Jing, Yu Bin, Li ZhongHua. Dosimetric comparison of 3DCRT and IMRT in treatment of primary hepatocellular carcinoma with portal vein tumor thrombus[J]. Journal of Clinical Hepatology, 2014, 30(3): 245-248. doi: 10.3969/j.issn.1001-5256.2014.03.012
[16]	Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001
[17]	Dai ShuYang, Huang Xing, Yang Tian, Shen Feng. Research advances in proton beam therapy for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(10): 744-747. doi: 10.3969/j.issn.1001-5256.2013.10.006
[18]	Wu DeQuan, Gao Feng, Sun DongSheng, Ceng ZhaoLin, Chou GongCai, Zhang XinChen. Surgical treatment of giant primary liver cancer[J]. Journal of Clinical Hepatology, 2011, 27(4): 372-374+390.
[20]	Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365.

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	张海欧，李牧，胡琪璐，张洪义，李宏奇. 放射治疗在肝脏恶性肿瘤的应用现状. 中国临床医生杂志. 2025(01): 11-14 .
2.	王雅迪，李学军，王宏伟. 立体定向放射联合靶向治疗肝癌脑转移1例. 临床军医杂志. 2022(03): 328-329 .
3.	段敬豪，孟祥娟，仇清涛，葛暄初，窦雪，陈进琥，尚东平，赵前锋. 基于3DCT、4DCT和多参数MR的原发性肝癌放疗靶区构建及剂量学对比研究. 中华肿瘤防治杂志. 2022(09): 650-655 .
4.	李陆军，钟宇行，覃伟光，卢敏华. Brain LAB立体定向放射治疗系统辐射等中心误差检测. 医疗装备. 2022(11): 9-11 .
5.	于程程，张贺诚，邓海燕. MRI对肝细胞癌SBRT的疗效评价及预测因素研究. 中国医疗设备. 2022(12): 91-94 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (656) PDF downloads(46)

Application of stereotactic body radiotherapy in small hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.05.050